Global Transcatheter Heart Valve Replacement and Repair Market Report 2023-2029 | |
The Transcatheter Heart Valve Replacement and Repair industry can be broken down into several segments, TAVR, TPVR and TMVR. Valvular heart diseases are associated with the person’s advancing age, caused by the congenital defects or inefficiency of valves to function. Valve dysfunction results in restricting physical activities that leads to decline in quality of life and even death. Hence, due to these reasons many years have been spent on developing heart valve devices in order to repair and replace the damaged heart valves. Over the past few years innovation and recent technological advancements have resulted in manufacturing of transcatheter heart valve that are less risky and need minimally invasive surgical procedure. Increase in number of people with valvular heart disease and rise in demand for minimally invasive surgical procedure will augment the growth of transcatheter heart valve replacement industry in the near future. The global key manufacturers of Transcatheter Heart Valve Replacement and Repair include Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, Venus Medtech, etc. In 2020, the global top four players had a share approximately 98.0% in terms of revenue. For more information, please contact the following e-mail address: Email: global@qyresearch.com Website: https://www.qyresearch.com | |
Target Prov.: All Provinces Target City : All Cities Last Update : May 20, 2024 3:31 AM Number of Views: 60 | Item Owner : Mortimer Contact Email: (None) Contact Phone: (None) |
Friendly reminder: Click here to read some tips. |